1,617
Views
78
CrossRef citations to date
0
Altmetric
Review

Clinical significance of chemokine receptor antagonists

, &
Pages 11-30 | Received 02 Nov 2019, Accepted 02 Jan 2020, Published online: 17 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sarah Dhaiban, Mena Al-Ani, Noha Mousaad Elemam & Azzam A Maghazachi. (2020) Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Journal of Inflammation Research 13, pages 619-633.
Read now

Articles from other publishers (77)

Yi-Ting Gong, Li-Jun Zhang, Yi-Chen Liu, Min Tang, Jia-Yi Lin, Xin-Yi Chen, Yi-Xu Chen, Yue Yan, Wei-Dong Zhang, Jin-Mei Jin & Xin Luan. (2023) Neutrophils as potential therapeutic targets for breast cancer. Pharmacological Research 198, pages 106996.
Crossref
Yiwen Chen, Yuhang Zhou, Ziyang Yan, Peilin Tong, Qiang Xia & Kang He. (2023) Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma. Cellular Oncology 46:6, pages 1595-1604.
Crossref
Mengke Li, Rui Qing, Fei Tao, Ping Xu & Shuguang Zhang. (2023) Dynamic Dimerization of Chemokine Receptors and Potential Inhibitory Role of Their Truncated Isoforms Revealed through Combinatorial Prediction. International Journal of Molecular Sciences 24:22, pages 16266.
Crossref
Jesse Santos, Ping Wang, Avishai Shemesh, Fengchun Liu, Tasha Tsao, Oscar A. Aguilar, Simon J. Cleary, Jonathan P. Singer, Ying Gao, Steven R. Hays, Jeffrey A. Golden, Lorriana Leard, Mary Ellen Kleinhenz, Nicholas A. Kolaitis, Rupal Shah, Aida Venado, Jasleen Kukreja, S. Sam Weigt, John A. Belperio, Lewis L. Lanier, Mark R. Looney, John R. Greenland & Daniel R. Calabrese. (2023) CCR5 drives NK cell–associated airway damage in pulmonary ischemia-reperfusion injury. JCI Insight 8:21.
Crossref
Ashokkumar Srinivasan, Allan Giri, Santhosh Kumar Duraisamy, Alexander Alsup, Mario Castro & Isaac Kirubakaran Sundar. (2023) Acute HDM exposure shows time-of-day and sex-based differences in the severity of lung inflammation and circadian clock disruption. Journal of Allergy and Clinical Immunology: Global 2:4, pages 100155.
Crossref
Chungwoo Shin, In-Cheol Baek, Won Kyoung Cho, Tai-Gyu Kim & Byung-Kyu Suh. (2023) Comprehensive analysis of chemokine gene polymorphisms in Korean children with autoimmune thyroid disease. Scientific Reports 13:1.
Crossref
Hongkun Zheng, Xinwei Cheng, Lu Jin, Shengzhou Shan, Jun Yang & Jia Zhou. (2023) Recent advances in strategies to target the behavior of macrophages in wound healing. Biomedicine & Pharmacotherapy 165, pages 115199.
Crossref
Kai Jing, Feng Chen, Xiaofei Shi, Jinmin Guo & Xia Liu. (2023) Dual effect of C–C motif chemokine receptor 5 on ischemic stroke: More harm than benefit?. European Journal of Pharmacology 953, pages 175857.
Crossref
Patrick Grudzien, Henry Neufeld, Mbasogo Ebe Eyenga & Vadim Gaponenko. (2023) Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation. Frontiers in Immunology 14.
Crossref
Yanchun Huang, Lijuan Wu, Yong Sun, Jiwen Li, Nan Mao, Yeqing Yang, Ming Zhao & Sichong Ren. (2023) CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysis. Heliyon 9:7, pages e18215.
Crossref
Lauri Urvas & Esther Kellenberger. (2023) Structural Insights into Molecular Recognition and Receptor Activation in Chemokine–Chemokine Receptor Complexes. Journal of Medicinal Chemistry 66:11, pages 7070-7085.
Crossref
Alexander O. Shpakov. (2023) Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands. International Journal of Molecular Sciences 24:7, pages 6187.
Crossref
Catherine S. Johnson & Leah M. Cook. (2023) Osteoid cell-derived chemokines drive bone-metastatic prostate cancer. Frontiers in Oncology 13.
Crossref
Fernando Ramírez-Jiménez, Gandhi Fernando Pavón-Romero, Juancarlos Manuel Velásquez-Rodríguez, Mariana Itzel López-Garza, José Fernando Lazarini-Ruiz, Katia Vanessa Gutiérrez-Quiroz & Luis M. Teran. (2023) Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future. Pharmaceuticals 16:2, pages 270.
Crossref
Zhan Li, Linlin Cheng, Haoting Zhan & Yongzhe Li. (2023) Chemokines and chemokine receptors in Behçet’s disease. Frontiers in Immunology 14.
Crossref
Davi Silva SantanaMarcos Jessé Abrahão Silva, Ana Beatriz Rocha de MarinVanessa Ladyanne da Silva CostaGabriel Silas Marinho SousaJuliana Gonçalves de SousaDihago Cardoso SilvaEliete Costa da CruzLuana Nepomuceno Gondim Costa Lima. (2023) The Influence Between C-C Chemokine Receptor 5 Genetic Polymorphisms and the Type-1 Human Immunodeficiency Virus: A 20-Year Review . AIDS Research and Human Retroviruses 39:1, pages 13-32.
Crossref
Joanna Bogacka, Katarzyna Pawlik, Katarzyna Ciapała, Agata Ciechanowska & Joanna Mika. (2022) CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy. International Journal of Molecular Sciences 23:24, pages 15638.
Crossref
P. Yazdanpanah, F. Vafaei & S. Afrouz. (2022) Diagnosis of Coronavirus Disease 2019 by Potential Laboratory Factors. Journal of Clinical Care and Skills 3:4, pages 149-154.
Crossref
Di Liu, Hongliang He, Fei Kong, Yixiang Cao, Fengchao Zang, Ming Ma, Ning Gu & Yu Zhang. (2022) A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging. Nano Today 47, pages 101689.
Crossref
Patrick Hunter, Alex L. Payne-Dwyer, Michael Shaw, Nathalie Signoret & Mark C. Leake. (2022) Single-molecule and super-resolved imaging deciphers membrane behavior of onco-immunogenic CCR5. iScience 25:12, pages 105675.
Crossref
Yinrong Wu, Zichao Yang, Kui Cheng, Huichang Bi & Jianjun Chen. (2022) Small molecule-based immunomodulators for cancer therapy. Acta Pharmaceutica Sinica B 12:12, pages 4287-4308.
Crossref
Jiawen Yang, Qiaoliang Zhu, Yifan Wu, Xiaojuan Qu, Haixia Liu, Biao Jiang, Di Ge & Xiaoling Song. (2022) Utilization of macrocyclic peptides to target protein-protein interactions in cancer. Frontiers in Oncology 12.
Crossref
Thomas T. Tapmeier, Jake H. Howell, Lei Zhao, Bartlomiej W. Papiez, Julia A. Schnabel, Ruth J. Muschel & Annamaria Gal. (2022) Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target. Oncogene 41:46, pages 5032-5045.
Crossref
Rienk Offringa, Lisa Kötzner, Bayard Huck & Klaus Urbahns. (2022) The expanding role for small molecules in immuno-oncology. Nature Reviews Drug Discovery 21:11, pages 821-840.
Crossref
Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui & Shoib Sarwar Siddiqui. (2022) Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact. Seminars in Cancer Biology 86, pages 436-449.
Crossref
Xue Wu, Lu Qian, Huadong Zhao, Wangrui Lei, Yanqing Liu, Xiaoling Xu, Jiawen Li, Zhi Yang, Du Wang, Yuchen Zhang, Yan Zhang, Ran Tang, Yang Yang & Ye Tian. (2022) CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis. Ageing Research Reviews, pages 101809.
Crossref
Zhan Li, Sihua Yu, Yongjun Jiang & Yajing Fu. (2022) Chemokines and chemokine receptors in allergic rhinitis: from mediators to potential therapeutic targets. European Archives of Oto-Rhino-Laryngology 279:11, pages 5089-5095.
Crossref
Kun Deng, Shenghua Lin, Zhanyu Xu, Junqi Qin, Liqiang Yuan, Yu Sun, Jiangbo Wei, Tiaozhan Zheng, Zhiwen Zheng, Fanglu QinShikang Li. (2022) A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma. Medicine 101:41, pages e30982.
Crossref
Haixia Zhang, Ke Yang, Feng Chen, Qianqian Liu, Jingyu Ni, Weilong Cao, Yunqing Hua, Feng He, Zhihao Liu, Lan Li & Guanwei Fan. (2022) Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications. Frontiers in Immunology 13.
Crossref
Thabani Sibiya, Terisha Ghazi & Anil Chuturgoon. (2022) The Potential of Spirulina platensis to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART). Nutrients 14:15, pages 3076.
Crossref
Giovanni Landoni, Alberto Zangrillo, Gioia Piersanti, Tommaso Scquizzato & Lorenzo Piemonti. (2022) The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials. Frontiers in Immunology 13.
Crossref
Rahaman Ademolu Ahmed, Khalid Olajide Adekoya, Chika Kingsley Onwuamah, Bolanle Olufunmilayo Oboh, Smita Swaminathan Iyer, Ayomide Samuel Oluwatosin, Rosemary Ajuma Audu & Oliver Chukwujekwu Ezechi. (2022) Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa. Viruses 14:6, pages 1270.
Crossref
Zhehua Shao, Yangxia Tan, Qingya Shen, Li Hou, Bingpeng Yao, Jiao Qin, Peiyu Xu, Chunyou Mao, Li-Nan Chen, Huibing Zhang, Dan-Dan Shen, Chao Zhang, Weijie Li, Xufei Du, Fei Li, Zhi-Hua Chen, Yi Jiang, H. Eric Xu, Songmin Ying, Honglei Ma, Yan Zhang & Huahao Shen. (2022) Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3. Cell Discovery 8:1.
Crossref
Sabrin R. M. Ibrahim, Hani Choudhry, Amer H. Asseri, Mahmoud A. Elfaky, Shaimaa G. A. Mohamed & Gamal A. Mohamed. (2022) Stachybotrys chartarum—A Hidden Treasure: Secondary Metabolites, Bioactivities, and Biotechnological Relevance. Journal of Fungi 8:5, pages 504.
Crossref
Stefanie Alexandra Eberle & Martin Gustavsson. (2022) A Scintillation Proximity Assay for Real-Time Kinetic Analysis of Chemokine–Chemokine Receptor Interactions. Cells 11:8, pages 1317.
Crossref
David J. Propper & Frances R. Balkwill. (2022) Harnessing cytokines and chemokines for cancer therapy. Nature Reviews Clinical Oncology 19:4, pages 237-253.
Crossref
Guangdi Li, Yali Wang & Erik De Clercq. (2022) Approved HIV reverse transcriptase inhibitors in the past decade. Acta Pharmaceutica Sinica B 12:4, pages 1567-1590.
Crossref
Kane Langdon, Geraldine Buitrago, Darren Pickering, Paul Giacomin, Alex Loukas & Nagaraja Haleagrahara. (2022) Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis. Inflammopharmacology 30:2, pages 527-535.
Crossref
Annette Gilchrist & Stephanie L. Echeverria. (2022) Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma. Frontiers in Endocrinology 13.
Crossref
Zhen Zeng, Tianxia Lan, Yuquan Wei & Xiawei Wei. (2022) CCL5/CCR5 axis in human diseases and related treatments. Genes & Diseases 9:1, pages 12-27.
Crossref
Ren-Lei Ji & Ya-Xiong Tao. 2022. Large Animals as Models for Human Diseases. Large Animals as Models for Human Diseases 179 213 .
Ren-Lei Ji & Ya-Xiong Tao. 2022. Large Animals as Models for Human Diseases. Large Animals as Models for Human Diseases 155 178 .
Noha Mousaad Elemam, Bariaa A. Khalil & Azzam A. Maghazachi. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 193 205 .
Dharmindra Dulal, Andrew R. Boring, David Terrero, Amit K. Tiwari & Dayanidhi Raman. 2022.
Bruna Kulmann-Leal, Joel Henrique Ellwanger & José Artur Bogo Chies. (2021) CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population. Frontiers in Immunology 12.
Crossref
Kazuhiko Matsuo, Osamu Yoshie & Takashi Nakayama. (2021) Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. Cancers 13:23, pages 6132.
Crossref
Mengmeng Liu, Jing Yang, Bushu Xu & Xing Zhang. (2021) Tumor metastasis: Mechanistic insights and therapeutic interventions. MedComm 2:4, pages 587-617.
Crossref
Daniel J. Sprague, Anthony E. Getschman, Tyler G. Fenske, Brian F. Volkman & Brian C. Smith. (2021) Trisubstituted 1,3,5-Triazines: The First Ligands of the sY12-Binding Pocket on Chemokine CXCL12. ACS Medicinal Chemistry Letters 12:11, pages 1773-1782.
Crossref
Karthik V Karuppusamy, Prathibha Babu & Saravanabhavan Thangavel. (2021) The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV. Stem Cell Reviews and Reports 17:5, pages 1607-1618.
Crossref
Naike Casagrande, Cinzia Borghese & Donatella Aldinucci. (2021) In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability. Haematologica 107:1, pages 287-291.
Crossref
Salma N. Tammam, Sara El Safy, Shahenda Ramadan, Sita Arjune, Eva Krakor & Sanjay Mathur. (2021) Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. Journal of Controlled Release 337, pages 258-284.
Crossref
Yujin Ding, Guangdi Li, Zhiguang Zhou & Tuo Deng. (2021) Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 121, pages 154802.
Crossref
Naz Chaudary, Richard P. Hill, Lukas Stulik & Michael Milosevic. (2021) The Oral CXCR4 Inhibitor X4-136 Improves Tumor Control and Reduces Toxicity in Cervical Cancer Treated With Radiation Therapy and Concurrent Chemotherapy. International Journal of Radiation Oncology*Biology*Physics 110:5, pages 1317-1324.
Crossref
Anthony J. DeSantis, Garrett A. Enten, Xianlong Gao & Matthias Majetschak. (2021) Chemokine receptor antagonists with α 1 -adrenergic receptor blocker activity . Journal of Basic and Clinical Physiology and Pharmacology 0:0.
Crossref
Bingjian Wen, Chengcheng Zhang, Jingwen Zhou, Zhengyan Zhang, Qishi Che, Hua Cao, Yan Bai, Jiao Guo & Zhengquan Su. (2021) Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacology & Therapeutics 222, pages 107752.
Crossref
Xin-yi Cao, Xiao Qian, Guo-dong Liu & Yu-hai Wang. (2021) Bioinformatics-based Identification of Key Pathways and Hub Genes of Traumatic Brain Injury in a Rat Model. Current Medical Science 41:3, pages 610-617.
Crossref
Rong Zhang, Tingting Miao, Min Qin, Chengsi Zhao, Wei Wang, Chengcheng Zhang, Xinjian Liu, Ying Chen, Ailing Chen & Yong Wang. (2021) CX3CL1 Recruits NK Cells Into the Central Nervous System and Aggravates Brain Injury of Mice Caused by Angiostrongylus cantonensis Infection. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Miao Miao, Erik De Clercq & Guangdi Li. (2021) Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. Biomedicines 9:4, pages 412.
Crossref
Anna Maria Trotta, Michela Aurilio, Crescenzo D’Alterio, Caterina Ieranò, Daria Di Martino, Antonio Barbieri, Antonio Luciano, Paolo Gaballo, Sara Santagata, Luigi Portella, Stefano Tomassi, Luciana Marinelli, Deborah Sementa, Ettore Novellino, Secondo Lastoria, Stefania Scala, Margret Schottelius & Salvatore Di Maro. (2021) Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors. Journal of Medicinal Chemistry 64:6, pages 3449-3461.
Crossref
José Luis Rodríguez‐Fernández & Olga Criado‐García. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 830 852 .
Jaisri R. Lingappa, Vishwanath R. Lingappa & Jonathan C. Reed. (2021) Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs—First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor. Viruses 13:3, pages 451.
Crossref
Supreet Kaur, Rashika Bansal, Sudarsan Kollimuttathuillam, Anusha Manje Gowda, Balraj Singh, Dhruv Mehta & Michael Maroules. (2021) The looming storm: Blood and cytokines in COVID-19. Blood Reviews 46, pages 100743.
Crossref
Guangdi Li, Ming Xu, Tingting Yue, Weijie Gu & Li Tan. (2021) Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq. Biochemical Pharmacology 185, pages 114485.
Crossref
Guangdi Li, Tingting Yue, Pan Zhang, Weijie Gu, Ling-Jie Gao & Li Tan. (2021) Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday. Molecules 26:4, pages 923.
Crossref
Chie Kudo-Saito, Yukinori Ozaki, Hiroshi Imazeki, Hideyuki Hayashi, Jun Masuda, Hiroki Ozawa & Yamato Ogiwara. (2021) Targeting Oncoimmune Drivers of Cancer Metastasis. Cancers 13:3, pages 554.
Crossref
Dylan Scott Eiger, Noelia Boldizsar, Christopher Cole Honeycutt, Julia Gardner & Sudarshan Rajagopal. (2021) Biased agonism at chemokine receptors. Cellular Signalling 78, pages 109862.
Crossref
Yang Wang, Yanlin Li, Di Jia, Jiali Zheng & Guoliang Wang. (2020) Correlation between single nucleotide polymorphisms in CXCR4 microRNA binding site and the susceptibility to knee osteoarthritis in Han Chinese population . Journal of Clinical Laboratory Analysis 35:2.
Crossref
Asim Kichloo, Michael Albosta, Akshay Kumar, Michael Aljadah, Mohamed Mohamed, Zain El-Amir, Farah Wani, Shakeel Jamal, Jagmeet Singh & Akif Kichloo. (2021) Emerging therapeutics in the management of COVID-19. World Journal of Virology 10:1, pages 1-29.
Crossref
Yang Li, Yushuo Xiao, Yuchen Chen & Kun Huang. (2021) Nano-based approaches in the development of antiviral agents and vaccines. Life Sciences 265, pages 118761.
Crossref
Peter P. Sordillo & Laura A. Sordillo. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 293 317 .
Elena Yeregui, Consuelo Viladés, Pere Domingo, Andra Ceausu, Yolanda María Pacheco, Sergi Veloso, Alexy Inciarte, Judit Vidal-González, Maria Peraire, Carles Perpiñán, Vicenç Falcó, Jenifer Masip, Verónica Alba, Montserrat Vargas, Anna Martí, Laia Reverté, Josep Mallolas, Francesc Vidal, Joaquim Peraire & Anna Rull. (2020) High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients. eBioMedicine 62, pages 103077.
Crossref
Bao-Chun Jiang, Tong Liu & Yong-Jing Gao. (2020) Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential. Pharmacology & Therapeutics 212, pages 107581.
Crossref
Cecilia A. Prator, Joanna Donatelli & Timothy J. Henrich. (2020) From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation. Current HIV/AIDS Reports 17:4, pages 385-393.
Crossref
Eddie W. Fakhouri, Stephen J. Peterson, Janish Kothari, Ragin Alex, Joseph I. Shapiro & Nader G. Abraham. (2020) Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm. Antioxidants 9:7, pages 636.
Crossref
Donatella Aldinucci, Cinzia Borghese & Naike Casagrande. (2020) The CCL5/CCR5 Axis in Cancer Progression. Cancers 12:7, pages 1765.
Crossref
Stefania Scala, Crescenzo D’Alterio, Samantha Milanesi, Alessandra Castagna, Roberta Carriero, Floriana Maria Farina, Massimo Locati & Elena Monica Borroni. (2020) New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM. Vaccines 8:2, pages 164.
Crossref
Anjani Devi Chintagunta, Mahesh Kumar, N. S. Sampath Kumar & S. P. Jeevan Kumar. 2020. Diagnostic Strategies for COVID-19 and other Coronaviruses. Diagnostic Strategies for COVID-19 and other Coronaviruses 51 71 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.